Pricing Log in Create free account

Cardiol Therapeutics Inc. (CRDL) vs Glass House Brands Inc. (GLAS)

Cardiol Therapeutics Inc. and Glass House Brands Inc. are both Drug Manufacturers Specialty & Generic companies. Glass House Brands Inc. is the larger, with a market value of $172.7M against $111.8M — 1.5× the size. Cardiol Therapeutics Inc. has the higher net margin (0.00% vs −36.2%) and the higher return on invested capital (0.00% vs −23.4%). Across the 14 metrics below, Cardiol Therapeutics Inc. leads on 9 and Glass House Brands Inc. on 5.

Valuation

Metric CRDL GLAS Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S n/m 1.14 2.08
P/B 6.16 2.79 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales n/m 1.35 2.87
Earnings yield (26.88%) (33.33%) (15.94%)
Free cash flow yield (16.13%) (18.18%) 0.00%

Profitability

Metric CRDL GLAS Drug Manufacturers Specialty & Generic median
Gross margin 0.00% 31.97% 53.51%
Operating margin 0.00% (23.18%) 0.00%
Net margin 0.00% (36.19%) (2.45%)
Free cash flow margin 0.00% (20.78%) 0.00%
Return on equity (171.13%) (74.02%) (0.80%)
Return on assets (124.40%) (19.78%) (1.67%)
Return on invested capital 0.00% (23.36%) 0.00%

Growth

Metric CRDL GLAS Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (15.38%) 5.22%
EPS growth (last fiscal year) 24.32% (161.90%) 42.91%
Revenue growth, 5-year CAGR — — 7.24%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CRDL GLAS Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.77 0.04
Current ratio 5.55 1.33 2.41
Net debt to EBITDA 0.62 (64.84) 1.01

Dividend

Metric CRDL GLAS Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric CRDL GLAS Drug Manufacturers Specialty & Generic median
Market cap 111.79m 172.67m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack